• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为抗癌剂的铜插层剂的最新进展。

Recent Advances in Copper Intercalators as Anticancer Agents.

作者信息

Shobha Devi C, Thulasiram B, Aerva Rajeshwar Rao, Nagababu Penumaka

机构信息

Department of Chemistry, RGUKT, Basar, Telangana State, India.

Inorganic & Physical Chemistry Division, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad, Telangana State, 500007, India.

出版信息

J Fluoresc. 2018 Sep;28(5):1195-1205. doi: 10.1007/s10895-018-2283-7. Epub 2018 Aug 31.

DOI:10.1007/s10895-018-2283-7
PMID:30171479
Abstract

Copper is a part of various enzymes and helps them to function properly. It can be effectively used to produce promising anticancer drugs and presently, many studies are being pursued worldwide on the development of copper-based complexes as potential anticancer drugs. Herein, we briefly discuss the importance of reactive oxygen species in biological applications and copper(II) complexes as anticancer drugs. The anti-angiogenic properties of mono-nuclear copper(II) complexes have been demonstrated by in vivo chick embryo angiogenesis analysis. The plausible mechanism behind anticancer activity of these complexes is by the formation of excessive intracellular Reactive Oxygen Species (ROS). ROS is a composite term used for oxygen derivative non-radicals and free radicals of highly reactive components, that enhances the killing response of immune cells to microbial invasion. Previous reports have shown that ROS plays an important role as a messenger in cell cycling and normal cell signal transduction. Graphical Abstract The generation of singlet oxygen and healing the tumor cells with singlet oxygen in presence of UV-light.

摘要

铜是多种酶的组成部分,并有助于它们正常发挥功能。它可有效地用于生产有前景的抗癌药物,目前,全球正在进行许多关于开发基于铜的配合物作为潜在抗癌药物的研究。在此,我们简要讨论活性氧在生物应用中的重要性以及作为抗癌药物的铜(II)配合物。单核铜(II)配合物的抗血管生成特性已通过体内鸡胚血管生成分析得到证实。这些配合物抗癌活性背后的可能机制是通过形成过量的细胞内活性氧(ROS)。ROS是一个复合术语,用于表示氧衍生物非自由基和高反应性成分的自由基,它增强了免疫细胞对微生物入侵的杀伤反应。先前的报道表明,ROS在细胞周期和正常细胞信号转导中作为信使发挥重要作用。图形摘要:单线态氧的产生以及在紫外光存在下用单线态氧治愈肿瘤细胞。

相似文献

1
Recent Advances in Copper Intercalators as Anticancer Agents.作为抗癌剂的铜插层剂的最新进展。
J Fluoresc. 2018 Sep;28(5):1195-1205. doi: 10.1007/s10895-018-2283-7. Epub 2018 Aug 31.
2
Synthesis of four binuclear copper(II) complexes: Structure, anticancer properties and anticancer mechanism.四种双核铜(II)配合物的合成:结构、抗癌特性及抗癌机制
Eur J Med Chem. 2015;96:360-8. doi: 10.1016/j.ejmech.2015.04.031. Epub 2015 Apr 14.
3
Four copper(II) compounds synthesized by anion regulation: Structure, anticancer function and anticancer mechanism.通过阴离子调控合成的四种铜(II)化合物:结构、抗癌功能及抗癌机制
Eur J Med Chem. 2016 Oct 4;121:399-409. doi: 10.1016/j.ejmech.2016.05.021. Epub 2016 May 14.
4
Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper(II) compounds.还原剂诱导抗癌铜(II)化合物产生活性氧物种的机制。
J Biol Inorg Chem. 2012 Mar;17(3):409-23. doi: 10.1007/s00775-011-0864-x. Epub 2011 Dec 22.
5
Self-activating nuclease and anticancer activities of copper(II) complexes with aryl-modified 2,6-di(thiazol-2-yl)pyridine.芳基修饰的 2,6-二(噻唑-2-基)吡啶铜(II)配合物的自激活核酸酶和抗癌活性。
Dalton Trans. 2013 Aug 28;42(32):11576-88. doi: 10.1039/c3dt50395j. Epub 2013 Jul 10.
6
Two new Cu(II) dipeptide complexes based on 5-methyl-2-(2'-pyridyl)benzimidazole as potential antimicrobial and anticancer drugs: Special exploration of their possible anticancer mechanism.两种新型基于 5-甲基-2-(2'-吡啶基)苯并咪唑的 Cu(II)二肽配合物作为潜在的抗菌和抗癌药物:对其可能的抗癌机制的特别探索。
Eur J Med Chem. 2018 Jun 25;154:220-232. doi: 10.1016/j.ejmech.2018.05.023. Epub 2018 May 21.
7
Copper(II) Complexes with Saccharinate and Glutamine as Antitumor Agents: Cytoand Genotoxicity in Human Osteosarcoma Cells.以糖精和谷氨酰胺为抗肿瘤剂的铜(II)配合物:对人骨肉瘤细胞的细胞毒性和遗传毒性
Anticancer Agents Med Chem. 2017;17(3):424-433. doi: 10.2174/1871520616666160513130204.
8
Novel mitochondria targeted copper(ii) complexes of ferrocenyl terpyridine and anticancer active 8-hydroxyquinolines showing remarkable cytotoxicity, DNA and protein binding affinity.新型线粒体靶向的二茂铁基三联吡啶和具有抗癌活性的 8-羟基喹啉铜(II)配合物,表现出显著的细胞毒性、DNA 和蛋白质结合亲和力。
Dalton Trans. 2017 Jan 3;46(2):396-409. doi: 10.1039/c6dt03660k.
9
Optically pure chiral copper(II) complexes of rosin derivative as attractive anticancer agents with potential anti-metastatic and anti-angiogenic activities.松香衍生物的光学纯手性铜(II)配合物作为有吸引力的抗癌剂,具有潜在的抗转移和抗血管生成活性。
Eur J Med Chem. 2019 Aug 15;176:175-186. doi: 10.1016/j.ejmech.2019.05.030. Epub 2019 May 14.
10
Copper(ii) thiosemicarbazone complexes induce marked ROS accumulation and promote nrf2-mediated antioxidant response in highly resistant breast cancer cells.铜(II)硫代半卡巴腙配合物诱导大量 ROS 积累,并促进高度耐药乳腺癌细胞中 nrf2 介导的抗氧化反应。
Dalton Trans. 2017 Mar 21;46(12):3833-3847. doi: 10.1039/c7dt00283a.

引用本文的文献

1
Synthesis, characterization, molecular docking studies, and theoretical calculations of novel Ni (II), Cu (II), and Zn (II) complexes based on benzothiazole derivative.基于苯并噻唑衍生物的新型镍(II)、铜(II)和锌(II)配合物的合成、表征、分子对接研究及理论计算
BMC Chem. 2025 Jul 4;19(1):202. doi: 10.1186/s13065-025-01576-1.
2
Synthesis, Structure, and Stability of Copper(II) Complexes Containing Imidazoline-Phthalazine Ligands with Potential Anticancer Activity.含咪唑啉-酞嗪配体且具有潜在抗癌活性的铜(II)配合物的合成、结构与稳定性
Pharmaceuticals (Basel). 2025 Mar 6;18(3):375. doi: 10.3390/ph18030375.
3
Metal-Based Drug-DNA Interactions and Analytical Determination Methods.

本文引用的文献

1
Heteroleptic Copper(I) Complexes of "Scorpionate" Bis-pyrazolyl Carboxylate Ligand with Auxiliary Phosphine as Potential Anticancer Agents: An Insight into Cytotoxic Mode.“异核”双吡唑基羧酸酯配体与辅助膦的铜(I)配合物作为潜在的抗癌剂:细胞毒性模式的深入了解。
Sci Rep. 2017 Mar 24;7:45229. doi: 10.1038/srep45229.
2
Transition Metal Intercalators as Anticancer Agents-Recent Advances.过渡金属嵌入剂作为抗癌剂——最新进展
Int J Mol Sci. 2016 Oct 31;17(11):1818. doi: 10.3390/ijms17111818.
3
Four Cu(ii) complexes based on antitumor chelators: synthesis, structure, DNA binding/damage, HSA interaction and enhanced cytotoxicity.
基于金属的药物-DNA 相互作用及其分析测定方法。
Molecules. 2024 Sep 13;29(18):4361. doi: 10.3390/molecules29184361.
4
Antioxidant and Antibacterial Screening and Hg(II) Sensing, Activities of Cu(II)pyridine-2,6-dicarboxylate Complexes.抗氧化和抗菌筛选及 Hg(II) 传感性能:Cu(II)吡啶-2,6-二羧酸配合物的研究
ChemistryOpen. 2024 Oct;13(10):e202400089. doi: 10.1002/open.202400089. Epub 2024 Jul 25.
5
Unveiling the promising anticancer effect of copper-based compounds: a comprehensive review.揭示铜基化合物的抗癌潜力:全面综述
J Cancer Res Clin Oncol. 2024 Apr 25;150(4):213. doi: 10.1007/s00432-024-05641-5.
6
Copper(II) Complexes with 2,2':6',2″-Terpyridine Derivatives Displaying Dimeric Dichloro-μ-Bridged Crystal Structure: Biological Activities from 2D and 3D Tumor Spheroids to In Vivo Models.具有 2,2':6',2″-三联吡啶衍生物的铜(II)配合物呈现二聚二氯桥联的晶体结构:从 2D 和 3D 肿瘤球体到体内模型的生物活性。
J Med Chem. 2024 Apr 11;67(7):5813-5836. doi: 10.1021/acs.jmedchem.4c00119. Epub 2024 Mar 22.
7
Effects of the tetravanadate [VO] anion on the structural, magnetic, and biological properties of copper/phenanthroline complexes.四钒酸盐[VO]阴离子对铜/菲咯啉配合物结构、磁性和生物性质的影响。
J Biol Inorg Chem. 2024 Feb;29(1):139-158. doi: 10.1007/s00775-023-02035-9. Epub 2024 Jan 4.
8
Synthesis and Biological Activity of a New Indenoisoquinoline Copper Derivative as a Topoisomerase I Inhibitor.新型苯并异喹啉铜衍生物的合成及其作为拓扑异构酶 I 抑制剂的生物活性。
Int J Mol Sci. 2023 Sep 26;24(19):14590. doi: 10.3390/ijms241914590.
9
A novel tetranuclear Cu(ii) complex for DNA-binding and anticancer activity.一种用于DNA结合和抗癌活性的新型四核铜(II)配合物。
RSC Adv. 2023 Sep 4;13(38):26324-26329. doi: 10.1039/d3ra03624c.
10
Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma.开发一种新型铜代谢相关风险模型以预测胃腺癌患者的预后和肿瘤微环境。
Front Pharmacol. 2023 May 22;14:1185418. doi: 10.3389/fphar.2023.1185418. eCollection 2023.
基于抗肿瘤螯合剂的四种铜(II)配合物:合成、结构、DNA结合/损伤、与人血清白蛋白的相互作用及增强的细胞毒性
Dalton Trans. 2016 May 10;45(19):8036-49. doi: 10.1039/c6dt00451b.
4
Synthesis, characterization, thermal properties and antiproliferative potential of copper(II) 4'-phenyl-terpyridine compounds.铜(II)4'-苯基-三联吡啶化合物的合成、表征、热性质及抗增殖潜力
Dalton Trans. 2016 Mar 28;45(12):5339-55. doi: 10.1039/c5dt02744f.
5
Copper(ii) mixed-ligand polypyridyl complexes with doxycycline - structures and biological evaluation.铜(II)与多西环素的混合配体多吡啶配合物——结构与生物学评价
Dalton Trans. 2016 Feb 21;45(7):3003-12. doi: 10.1039/c5dt04405g. Epub 2016 Jan 13.
6
Interaction of DNA with Simple and Mixed Ligand Copper(II) Complexes of 1,10-Phenanthrolines as Studied by DNA-Fiber EPR Spectroscopy.通过DNA纤维电子顺磁共振光谱研究1,10-菲咯啉的简单和混合配体铜(II)配合物与DNA的相互作用。
Int J Mol Sci. 2015 Sep 21;16(9):22754-80. doi: 10.3390/ijms160922754.
7
Antiangiogenic activity of mononuclear copper(II) polypyridyl complexes for the treatment of cancers.单核铜(II) 多吡啶配合物的抗血管生成活性用于癌症治疗。
J Med Chem. 2015 Jul 9;58(13):5226-41. doi: 10.1021/acs.jmedchem.5b00651. Epub 2015 Jun 24.
8
Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.用单光子发射计算机断层扫描(SPECT)评估(99m)Tc-HYNIC-TMTP1作为一种靶向转移灶的肿瘤归巢显像剂。
Nucl Med Biol. 2015 Mar;42(3):256-62. doi: 10.1016/j.nucmedbio.2014.11.001. Epub 2014 Nov 13.
9
Copper phenanthrene oxidative chemical nucleases.铜菲咯啉氧化化学核酸酶
Inorg Chem. 2014 May 19;53(10):5392-404. doi: 10.1021/ic500914j. Epub 2014 May 7.
10
Two water-soluble copper(II) complexes: synthesis, characterization, DNA cleavage, protein binding activities and in vitro anticancer activity studies.两种水溶性铜(II)配合物:合成、表征、DNA裂解、蛋白质结合活性及体外抗癌活性研究
J Inorg Biochem. 2014 Aug;137:46-56. doi: 10.1016/j.jinorgbio.2014.03.015. Epub 2014 Apr 8.